Raltegravir monohydrate

Raltegravir monohydrate

The hydrated title compound [systematic name: N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-{1-methyl-1-[(5-methyl-1,3,4-oxadiazol-2-ylcarbonyl)amino]ethyl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide monohydrate], C20H21FN6O5·H2O, is recognised as the first HIV integrase inhibitor. In the molecule...

Full description

Bibliographic Details
Main Authors:	H. S. Yathirajan, Brian J. Anderson, Jerry P. Jasinski, Thammarse S. Yamuna, Manpreet Kaur
Format:	Article
Language:	English
Published:	International Union of Crystallography 2013-12-01
Series:	Acta Crystallographica Section E
Online Access:	http://scripts.iucr.org/cgi-bin/paper?S1600536813029747

Similar Items

Pyrimethaminium 2-{[4-(trifluoromethyl)phenyl]sulfanyl}benzoate dimethyl sulfoxide monosolvate
by: Thammarse S. Yamuna, et al.
Published: (2014-06-01)

5-(4-Fluorophenyl)-2H-pyrazol-1-ium 2,2,2-trifluoroacetate
by: Thammarse S. Yamuna, et al.
Published: (2014-04-01)

Methyl 2-[4-(trifluoromethyl)phenylsulfanyl]benzoate
by: Thammarse S. Yamuna, et al.
Published: (2013-11-01)

Crystal structures of 4-(pyrimidin-2-yl)piperazin-1-ium chloride and 4-(pyrimidin-2-yl)piperazin-1-ium nitrate
by: Thammarse S. Yamuna, et al.
Published: (2014-10-01)

2-[4-(Trifluoromethyl)phenylsulfanyl]benzoic acid
by: Thammarse S. Yamuna, et al.
Published: (2013-11-01)

4-Hydroxy-5-(2-methoxyphenoxy)-2,2′-bipyrimidin-6(5H)-one dihydrate
by: Thammarse S. Yamuna, et al.
Published: (2013-11-01)

Enrofloxacinium oxalate
by: Thammarse S. Yamuna, et al.
Published: (2014-02-01)

Two tautomers in the same crystal: 3-(4-fluorophenyl)-1H-pyrazole and 5-(4-fluorophenyl)-1H-pyrazole
by: Thammarse S. Yamuna, et al.
Published: (2014-09-01)

Flupentixol tartrate
by: Thammarse S. Yamuna, et al.
Published: (2014-02-01)

{2-[(1H-Indol-3-ylmethylidene)amino]-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl}(phenyl)methanone
by: Manpreet Kaur, et al.
Published: (2014-04-01)

Crystal structure of N-(3-benzoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)benzamide
by: Manpreet Kaur, et al.
Published: (2014-09-01)

1-Piperonylpiperazinium 4-nitrobenzoate monohydrate
by: Channappa N. Kavitha, et al.
Published: (2014-03-01)

Bosentan monohydrate
by: Thomas Gerber, et al.
Published: (2013-01-01)

3-Amino-1H-pyrazol-2-ium trifluoroacetate
by: T. S. Yamuna, et al.
Published: (2013-09-01)

3-(1H-Imidazol-1-yl)propanaminium picrate
by: T. S. Yamuna, et al.
Published: (2013-10-01)

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-phenylacetamide
by: H. S. Yathirajan, et al.
Published: (2013-12-01)

Crystal structure of 1-(3-chlorophenyl)piperazin-1-ium picrate–picric acid (2/1)
by: Channappa N. Kavitha, et al.
Published: (2014-11-01)

Bis{4-[(1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}methane
by: Channappa N. Kavitha, et al.
Published: (2013-11-01)

N-(4-Chloro-1,3-benzothiazol-2-yl)-2-(3-methylphenyl)acetamide monohydrate
by: H. S. Yathirajan, et al.
Published: (2011-10-01)

Flunarizinium isonicotinate
by: Channappa N. Kavitha, et al.
Published: (2014-06-01)

[2-(Biphenyl-4-yl)-1,3-thiazol-4-yl]methanol
by: Manpreet Kaur, et al.
Published: (2012-10-01)

4-Acetylpiperazinium picrate
by: Channappa N. Kavitha, et al.
Published: (2014-06-01)

4-(3-Fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid
by: Manpreet Kaur, et al.
Published: (2013-12-01)

Crystal structure of 3-benzoyl-2-[(5-bromo-2-hydroxy-3-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[b]thiophene
by: Manpreet Kaur, et al.
Published: (2015-02-01)

HIV resistance to raltegravir
by: Clavel François
Published: (2009-11-01)

Desvenlafaxinium chloranilate ethyl acetate solvate
by: Manpreet Kaur, et al.
Published: (2013-10-01)

(2E)-3-{4-[(1H-1,3-Benzimidazol-2-yl)methoxy]-3-ethoxyphenyl}-1-(4-bromophenyl)prop-2-en-1-one monohydrate
by: Jerry P. Jasinski, et al.
Published: (2011-04-01)

4-(Furan-2-carbonyl)piperazin-1-ium 3,5-dinitrobenzoate
by: Channappa N. Kavitha, et al.
Published: (2014-06-01)

Crystal structure of desvenlafaxinium 3,5-dinitrobenzoate 3,5-dinitrobenzoic acid monohydrate, C30H35N5O15
by: Kaur Manpreet, et al.
Published: (2014-12-01)

Raltegravir use in special populations
by: Johnson Margaret
Published: (2009-11-01)

Raltegravir in treatment naïve patients
by: Cossarini F, et al.
Published: (2009-11-01)

Drug-drug interactions with raltegravir
by: Burger David M
Published: (2009-11-01)

Crystal structure of N-[3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl]-2-[(E)-(2-hydroxybenzylidene)amino]acetamide
by: Manpreet Kaur, et al.
Published: (2014-09-01)

[2-(Benzylideneamino)-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl](phenyl)methanone
by: Manpreet Kaur, et al.
Published: (2014-05-01)

1-(3,4-Dimethoxyphenyl)-3-phenylprop-2-en-1-one
by: Basavaiah Umesha, et al.
Published: (2014-03-01)

Crystal and Molecular Structure Studies of Ethyl 4-(4-Hydroxyphenyl)-6-(6-methoxy-2-naphthyl)-2-oxocyclohex-3-ene-1-carboxylate and Ethyl 4-(3-Bromophenyl)-6-(6-methoxy-2-naphthyl)-2-oxocyclohex-3-ene-1-carboxylate
by: Badiadka Narayana, et al.
Published: (2012-08-01)

Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008-06-01)

Role of raltegravir in the management of HIV-1 infection
by: Okeke NL, et al.
Published: (2011-07-01)

4-Amino-3-(4-hydroxybenzyl)-1H-1,2,4-triazole-5(4H)-thione
by: B. K. Sarojini, et al.
Published: (2014-01-01)

4-[(E)-(4-Chlorobenzylidene)amino]-3-methyl-1H-1,2,4-triazole-5(4H)-thione
by: B. K. Sarojini, et al.
Published: (2014-01-01)